Retraction: Oncogenic fibulin-5 promotes nasopharyngeal carcinoma cell metastasis through the FLJ10540/AKT pathway and correlates with poor prognosis (PLoS ONE (2013) 8: 12 (e84218) DOI: 10.1371/journal.pone.0084218);Oncogenic fibulin-5 promotes nasopharyngeal carcinoma cell metastasis through the FLJ10540/AKT pathway and correlates with poor prognosis

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Hwang, Chung Feng ^a,b   Shiu, Li Yen ^c   Su, Li Jen ^d   Yin, Yu Fang ^a,b   Wang, Wei Sheng ^a,b   Huang, Shun Chen ^a   Chiu, Tai Jan ^a   Huang, Chao Cheng ^a,b   Zhen, Yen Yi ^a   Tsai, Hsin Ting ^a,b   Fang, Fu Min ^a,b   Huang, Tai Lin ^a   Chen, Chang Han ^a,b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c CHANG BING SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

^d NATIONAL CENTRAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; FIBULIN 5; FLJ10540 PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CARCINOGENESIS; CELL MIGRATION; CELL MOTILITY; CELL NUCLEUS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; METASTASIS INHIBITION; MULTIVARIATE ANALYSIS; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SURVIVAL TIME; TUMOR INVASION; UNIVARIATE ANALYSIS;

ACTIVE TRANSPORT, CELL NUCLEUS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL NUCLEUS; CELL PROLIFERATION; DISEASE PROGRESSION; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NUCLEAR PROTEINS; ONCOGENES; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-AKT; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS;

EID: 84893564877     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0227931     Document Type: Erratum

References (39)

1. Zhou X, Cui J, Macias V, Kajdacsy-Balla AA, Ye H et al. (2007) The progress on genetic analysis of nasopharyngeal carcinoma. Comp Funct Genomics: 57513: 57513. PubMed: 18288251.
2. Yoshizaki T, Ito M, Murono S, Wakisaka N, Kondo S et al. (2012) Current understanding and management of nasopharyngeal carcinoma. Auris Nasus Larynx 39: 137-144. doi:10.1016/j.anl.2011.02.012. PubMed: 21592702.
3. Hwang CF, Chien CY, Huang SC, Yin YF, Huang CC et al. (2010) Fibulin-3 is associated with tumour progression and a poor prognosis in nasopharyngeal carcinomas and inhibits cell migration and invasion via suppressed AKT activity. J Pathol 222: 367-379. doi:10.1002/path. 2776. PubMed: 20927779.
4. Ma BB, Hui EP, Chan AT (2008) Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: current and future directions. Cancer Sci 99: 1311-1318. doi:10.1111/j. 1349-7006.2008.00836.x. PubMed: 18498420.
5. Chou J, Lin YC, Kim J, You L, Xu Z et al. (2008) Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis. Head Neck 30: 946-963. doi:10.1002/hed.20833. PubMed: 18446839. (Pubitemid 352008957)
6. Argraves WS, Greene LM, Cooley MA, Gallagher WM (2003) Fibulins: physiological and disease perspectives. EMBO Rep 4: 1127-1131. doi:10.1038/sj.embor.7400033. PubMed: 14647206. (Pubitemid 38088406)
7. Nakamura T, Lozano PR, Ikeda Y, Iwanaga Y, Hinek A et al. (2002) Fibulin-5/DANCE is essential for elastogenesis in vivo. Nature 415: 171-175. doi:10.1038/415171a. PubMed: 11805835. (Pubitemid 34059518)
8. Schiemann WP, Blobe GC, Kalume DE, Pandey A, Lodish HF (2002) Context-specific effects of fibulin-5 (DANCE/EVEC) on cell proliferation, motility, and invasion. Fibulin-5 is induced by transforming growth factor-beta and affects protein kinase cascades. J Biol Chem 277: 27367-27377. doi:10.1074/jbc.M200148200. PubMed: 12021267. (Pubitemid 34951757)
9. de Vega S, Iwamoto T, Yamada Y (2009) Fibulins: multiple roles in matrix structures and tissue functions. Cell Mol Life Sci 66: 1890-1902. doi:10.1007/s00018-009-8632-6. PubMed: 19189051.
10. Yue W, Sun Q, Landreneau R, Wu C, Siegfried JM et al. (2009) Fibulin-5 suppresses lung cancer invasion by inhibiting matrix metalloproteinase-7 expression. Cancer Res 69: 6339-6346. doi:10.1158/0008-5472.CAN-09-0398. PubMed: 19584278.
11. Albig AR, Schiemann WP (2005) Fibulin-5 function during tumorigenesis. Future Oncol 1: 23-35. doi:10.1517/14796694.1.1.23. PubMed: 16555973.
12. Sullivan KM, Bissonnette R, Yanagisawa H, Hussain SN, Davis EC (2007) Fibulin-5 functions as an endogenous angiogenesis inhibitor. Lab Invest 87: 818-827. doi:10.1038/labinvest.3700594. PubMed: 17607303. (Pubitemid 47077259)
13. Yanagisawa H, Schluterman MK, Brekken RA (2009) Fibulin-5, an integrin-binding matricellular protein: its function in development and disease. J Cell Commun Signal 3: 337-347. doi:10.1007/s12079-009-0065-3. PubMed: 19798595.
14. Albig AR, Neil JR, Schiemann WP (2006) Fibulins 3 and 5 antagonize tumor angiogenesis in vivo. Cancer Res 66: 2621-2629. doi:10.1158/0008-5472.CAN-04- 4096. PubMed: 16510581.
15. Hu Z, Ai Q, Xu H, Ma X, Li HZ et al. (2011) Fibulin-5 is down-regulated in urothelial carcinoma of bladder and inhibits growth and invasion of human bladder cancer cell line 5637. Urol Oncol 29: 430-435. doi:10.1016/j.urolonc. 2009.06.004. PubMed: 19767220.
16. Wlazlinski A, Engers R, Hoffmann MJ, Hader C, Jung V et al. (2007) Downregulation of several fibulin genes in prostate cancer. Prostate 67: 1770-1780. doi:10.1002/pros.20667. PubMed: 17929269. (Pubitemid 350228729)
17. Fang FM, Tsai WL, Go SF, Ho MW, Wu JM et al. (2001) Implications of quantitative tumor and nodal regression rates for nasopharyngeal carcinomas after 45 Gy of radiotherapy. Int J Radiat Oncol Biol Phys 50: 961-969. doi:10.1016/S0360-3016(01)01531-0. PubMed: 11429224.
18. Chen CH, Su CY, Chien CY, Huang CC, Chuang HC et al. (2008) Overexpression of beta2-microglobulin is associated with poor survival in patients with oral cavity squamous cell carcinoma and contributes to oral cancer cell migration and invasion. Br J Cancer 99: 1453-1461. doi:10.1038/sj.bjc. 6604698. PubMed: 18841160.
19. Chen CH, Lu PJ, Chen YC, Fu SL, Wu KJ et al. (2007) FLJ10540-elicited cell transformation is through the activation of PI3-kinase/AKT pathway. Oncogene 26: 4272-4283. doi:10.1038/sj.onc.1210207. PubMed: 17237822. (Pubitemid 46975797)
20. Chen CH, Chien CY, Huang CC, Hwang CF, Chuang HC et al. (2009) Expression of FLJ10540 is correlated with aggressiveness of oral cavity squamous cell carcinoma by stimulating cell migration and invasion through increased FOXM1 and MMP-2 activity. Oncogene 28: 2723-2737. doi:10.1038/onc.2009.128. PubMed: 19525975.
21. Lee YH, Albig AR, Regner M, Schiemann BJ, Schiemann WP (2008) Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF-beta in mammary epithelial cells via a MMP-dependent mechanism. Carcinogenesis 29: 2243-2251. doi:10.1093/carcin/bgn199. PubMed: 18713838.
22. Lin CT, Wong CI, Chan WY, Tzung KW, Ho JK et al. (1990) Establishment and characterization of two nasopharyngeal carcinoma cell lines. Lab Invest 62: 713-724. PubMed: 2162997. (Pubitemid 20213689)
23. Glaser R, Zhang HY, Yao KT, Zhu HC, Wang FX et al. (1989) Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas. Proc Natl Acad Sci U S A 86: 9524-9528. doi:10.1073/pnas. 86.23.9524. PubMed: 2556716.
24. Bhattacharya N, Sarno A, Idler IS, Führer M, Zenz T et al. (2010) High-throughput detection of nuclear factor-kappaB activity using a sensitive oligo-based chemiluminescent enzyme-linked immunosorbent assay. Int J Cancer 127: 404-411. PubMed: 19924814.
25. Chen CH, Chuang HC, Huang CC, Fang FM, Huang HY et al. (2013) Overexpression of Rap-1A indicates a poor prognosis for oral cavity squamous cell carcinoma and promotes tumor cell invasion via Aurora-A modulation. Am J Pathol 182: 516-528. doi:10.1016/j.ajpath. 2012.10.023. PubMed: 23219753.
26. Lai JM, Huang CY, Chen CH (2010) Using siRNA to uncover novel oncogenic signaling pathways. Methods Mol Biol 623: 231-242. doi:10.1007/978-1-60761-588- 0-15. PubMed: 20217555.
27. Chen CH, Lai JM, Chou TY, Chen CY, Su LJ et al. (2009) VEGFA upregulates FLJ10540 and modulates migration and invasion of lung cancer via PI3K/AKT pathway. PLOS ONE 4: e5052. doi:10.1371/journal.pone.0005052. PubMed: 19337377.
28. Chen CH, Shiu LY, Su LJ, Huang CY, Huang SC et al. (2012) FLJ10540 is associated with tumor progression in nasopharyngeal carcinomas and contributes to nasopharyngeal cell proliferation, and metastasis via osteopontin/CD44 pathway. J Transl Med 10: 93. doi:10.1186/1479-5876-10-93. PubMed: 22591637.
29. Geiger TR, Peeper DS (2009) Metastasis mechanisms. Biochim Biophys Acta 1796: 293-308. PubMed: 19683560.
30. Møller HD, Ralfkjaer U, Cremers N, Frankel M, Pedersen RT et al. (2011) Role of fibulin-5 in metastatic organ colonization. Mol Cancer Res 9: 553-563. doi:10.1158/1541-7786.MCR-11-0093. PubMed: 21454378.
31. Fabbro M, Zhou BB, Takahashi M, Sarcevic B, Lal P et al. (2005) Cdk1/Erk2- and Plk1-dependent phosphorylation of a centrosome protein, Cep55, is required for its recruitment to midbody and cytokinesis. Dev Cell 9: 477-488. doi:10.1016/j.devcel.2005.09.003. PubMed: 16198290. (Pubitemid 41430731)
32. Sakai M, Shimokawa T, Kobayashi T, Matsushima S, Yamada Y et al. (2006) Elevated expression of C10orf3 (chromosome 10 open reading frame 3) is involved in the growth of human colon tumor. Oncogene 25: 480-486. PubMed: 16170351. (Pubitemid 43117633)
33. Zhang W, Zeng Z, Zhou Y, Xiong W, Fan S et al. (2009) Identification of aberrant cell cycle regulation in Epstein-Barr virus-associated nasopharyngeal carcinoma by cDNA microarray and gene set enrichment analysis. Acta Biochim Biophys Sin (Shanghai) 41: 414-428. doi:10.1093/abbs/gmp025. PubMed: 19430707.
34. Mäkitie AA, MacMillan C, Ho J, Shi W, Lee A et al. (2003) Loss of p16 expression has prognostic significance in human nasopharyngeal carcinoma. Clin Cancer Res 9: 2177-2184. PubMed: 12796384. (Pubitemid 36687641)
35. Vogelstein B, Kinzler KW (2004) Cancer genes and the pathways they control. Nat Med 10: 789-799. doi:10.1038/nm1087. PubMed: 15286780. (Pubitemid 39070849)
36. Kasahara M, Takahashi Y, Nagata T, Asai S, Eguchi T et al. (2000) Thymidylate synthase expression correlates closely with E2F1 expression in colon cancer. Clin Cancer Res 6: 2707-2711. PubMed: 10914714. (Pubitemid 30482108)
37. Nahle Z, Polakoff J, Davuluri RV, McCurrach ME, Jacobson MD et al. (2002) Direct coupling of the cell cycle and cell death machinery by E2F. Nat Cell Biol 4: 859-864. doi:10.1038/ncb868. PubMed: 12389032. (Pubitemid 35331360)
38. Crosby ME, Almasan A (2004) Opposing roles of E2Fs in cell proliferation and death. Cancer Biol Ther 3: 1208-1211. doi:10.4161/cbt.3.12.1494. PubMed: 15662116. (Pubitemid 41350953)
39. Yang HJ, Cho YJ, Kim HS, Chang MS, Sung MW et al. (2001) Association of p53 and BCL-2 expression with Epstein-Barr virus infection in the cancers of head and neck. Head Neck 23: 629-636. doi:10.1002/hed.1089. PubMed: 11443745. (Pubitemid 32643106)